Maturation of PNN and ErbB4 Signaling in Area CA2 during Adolescence Underlies the Emergence of PV Interneuron Plasticity and Social Memory. by Domínguez, Soledad (author) et al.
ArticleMaturation of PNN and ErbB4 Signaling in Area CA2
during Adolescence Underlies the Emergence of PV
Interneuron Plasticity and Social MemoryGraphical AbstractHighlightsd Inhibitory plasticity from PV+ interneurons in area CA2
emerges at the end of adolescence
d The control of GABA release by the PNN and ErbB4 matures
at the end of adolescence
d Signaling through the PNN via NRG1 and ErbB4 is required for
iLTD induction
d Preventing iLTD induction in CA2 in vivo impairs social
memory formationDomı´nguez et al., 2019, Cell Reports 29, 1099–1112
October 29, 2019 ª 2019 The Author(s).
https://doi.org/10.1016/j.celrep.2019.09.044Authors
Soledad Domı´nguez,
Christophe Cle´ment Rey,
Ludivine Therreau, ..., Laure Verret,
Rebecca Ann Piskorowski,
Vivien Chevaleyre
Correspondence
vivien.chevaleyre@parisdescartes.fr
In Brief
Dominguez et al. describe the
mechanisms involved in the emergence
of a form of long-term plasticity at
inhibitory synapses from parvalbumin-
expressing interneurons in mouse
hippocampal area CA2. Maturation of this
plasticity potentially underlies the
emergence of social memory during late
adolescence.
Cell Reports
ArticleMaturation of PNN and ErbB4 Signaling in Area CA2
during Adolescence Underlies the Emergence
of PV Interneuron Plasticity and Social Memory
Soledad Domı´nguez,1 Christophe Cle´ment Rey,2 Ludivine Therreau,1,4 Aure´lien Fanton,1 Dominique Massotte,3
Laure Verret,2 Rebecca Ann Piskorowski,1 and Vivien Chevaleyre1,5,*
1INSERM UMR 1266, Institute of Psychiatry and Neuroscience of Paris, Team Synaptic Plasticity and Neural Networks, 102-108 Rue de la
Sante´, 75014 Paris, France
2Research Center on Animal Cognition, Center for Integrative Biology, Toulouse University, CNRS, UPS, Toulouse, France
3Institut des Neurosciences Cellulaires et Inte´gratives, CNRS UPR 3212, 5 Rue Blaise Pascal, 67084 Strasbourg, France
4Inovarion, Centre de Recherche en Sciences du Vivant, 251 Rue St Jacques, 75005 Paris, France
5Lead Contact
*Correspondence: vivien.chevaleyre@parisdescartes.fr
https://doi.org/10.1016/j.celrep.2019.09.044SUMMARY
Adolescence is a vulnerable period characterized
bymajor cognitive changes. Themechanisms under-
lying the emergence of new cognitive functions are
poorly understood. We find that a long-term depres-
sion of inhibitory transmission (iLTD) from parvalbu-
min-expressing (PV+) interneurons in the hippocam-
pal area Cornu Ammonis 2 (CA2) is absent in young
mice but emerges at the end of adolescence. We
demonstrate that the maturation of both the peri-
neuronal net (PNN) and signaling through ErbB4 is
required for this plasticity. Furthermore, we demon-
strate that social recognition memory displays the
same age dependence as iLTD and is impaired by
targeted degradation of the PNN or iLTD blockade
in area CA2. Our data reveal an unusual develop-
mental rule for plasticity at the PV+ interneuron
transmission in area CA2 and indicate that this plas-
ticity is involved in the emergence of higher cognitive
function, such as social memory formation, in late
adolescence.
INTRODUCTION
The hippocampus is a critical structure for learning and mem-
ory formation. Area Cornu Ammonis 2 (CA2) of the hippocam-
pus has emerged as an important region for social memory
formation (Hitti and Siegelbaum, 2014; Stevenson and Cald-
well, 2014; Wersinger et al., 2002). Furthermore, this region
may play an important role in the generation of hippocam-
pal-wide network activity (Kay et al., 2016; Oliva et al.,
2016). The cellular composition in area CA2 is unique in that
the density of several sub-classes of interneurons, including
parvalbumin-expressing (PV+) interneurons (INs), is higher
than in the other hippocampal areas (Botcher et al., 2014).
The inhibitory transmission from PV+ INs expresses a uniqueCell Rep
This is an open access article under the CC BY-Nlong-term depression (iLTD) onto CA2 pyramidal neurons
(PNs) that is mediated by delta opioid receptor (DOR) activa-
tion (Piskorowski and Chevaleyre, 2013).
Area CA2 is particularly vulnerable in several psychiatric dis-
eases, including schizophrenia and dementia (Chevaleyre and
Piskorowski, 2016). Specifically, the density of PV+ INs in this
region has been reported to be decreased in human post-mor-
tem studies of schizophrenic and bipolar patients (Knable
et al., 2004). In a mouse model of the 22q11.2 deletion syn-
drome, we reported a specific decrease in PV+ IN density in
area CA2, a decrease in synaptic transmission and plasticity
from PV+ INs, and a deficit in social memory (Piskorowski
et al., 2016). These changes in PV+ IN properties occurred
at the end of adolescence, indicating that PV+ INs in area
CA2 undergo developmental changes during this time period.
Adolescence is a vulnerable transition period characterized by
major behavioral and cognitive changes, and human imaging
studies have demonstrated that the brain undergoes consider-
able structural development and remodeling during this period
(Blakemore, 2008; Giedd et al., 1999). However, the cellular
and synaptic changes that occur in the hippocampus are not
understood.
The perineuronal net (PNN), a dense specialized extracel-
lular matrix, encases PV+ IN soma and dendrites. This struc-
ture increases in density during postnatal development
and often prohibits plasticity of synaptic inputs onto PV+
INs, contributing to the closure of developmental critical
periods (Hensch, 2005; Horii-Hayashi et al., 2015) by regu-
lating PV+ IN signaling (Cabungcal et al., 2013). Furthermore,
it has been reported that the loss of this structure in the
hippocampus is linked to schizophrenia (Berretta et al.,
2015; Bitanihirwe and Woo, 2014). While rare, the PNN has
been shown to also surround pyramidal cells in the cortex
and hippocampus, where it surrounds CA2 PNs (Br€uckner
et al., 2003). It has been proposed that the PNN surrounding
CA2 PNs plays a role in limiting excitatory postsynaptic
plasticity during early postnatal development (Carstens et al.,
2016). However, the role of the PNN in controlling inhibitory
plasticity during later stages of adolescence is not known.orts 29, 1099–1112, October 29, 2019 ª 2019 The Author(s). 1099
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Figure 1. LTD of Inhibitory Transmission in Area CA2 Emerges at the
End of Adolescence
(A) Time course of normalized IPSC amplitudes recorded in CA2 PNs evoked
by stimulation in the SR in the presence of a-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic acid (AMPA) and N-Methyl-d-aspartate (NMDA) receptor
blockers. A high-frequency stimulation (HFS; 100 pulses at 100 Hz repeated
twice) triggered an iLTD in slices prepared at postnatal days (P) 33–45 (filled
circles, n = 8) but only triggered a transient depression at P17–P21 (open
circles, n = 5). Averaged sample traces at the time points indicated are
shown on the right.
(B) The summary graph of the averaged iLTD magnitude at different ages
shows that the iLTD was not induced with the HFS before P27–P32 but was
induced at P33–P45 and remained stable in adulthood.
(C) The HFS triggered a significant increase in the paired pulse ratio (PPR) at
P33–P45 (n = 8, p = 0.011) and >P70 (n = 8, p = 0.0058) but not at P17–P21 (n =
5, p = 0.58), P22–P26 (n = 7, p = 0.23), or P27–P32 (n = 6, p = 0.47).
(D) Left: time course of the effect of 15-min application of 5 mM of the selective
DOR agonist (DPDPE) on normalized IPSC amplitude at P26–P30 and >P35. In
contrast to the lasting depression-mediated DPDPE application after P35
(filled circles, n = 8), DPDPE triggered a transient depression at P26–P30 (open
circles, n = 6). Center: averaged sample traces at the time indicated. Right:
significant change in the PPR after the HFS at time points over P35 (n = 8, p =
0.014), but not at P26–P30 (n = 6, p = 0.89). Error bars show SEM.In this study, we aimed to examine the cellular and molecular
components that change in area CA2 during late adolescence
and to determine if these changes brought about new cogni-
tive abilities.1100 Cell Reports 29, 1099–1112, October 29, 2019RESULTS
Plasticity between PV+ INs and CA2 PNs Emerges at the
End of Adolescence
The decrease in the density of PV+ INs and in inhibitory transmis-
sion and plasticity observed in area CA2 in a mouse model of
the 22q11.2 deletion syndrome (Piskorowski et al., 2016) only
occurred after the fifth postnatal week, suggesting that
changes occur in PV+ IN physiology during this developmental
period. Therefore, we asked whether the plasticity of PV+ INs
could be developmentally regulated. We performed whole-cell
voltage clamp recordings of CA2 PNs to monitor inhibitory
post-synaptic currents (IPSCs) evoked by stratum radiatum
(SR) stimulation. We applied a high-frequency stimulation
(HFS) to induce iLTD in area CA2. During postnatal days (P)
33–45, this stimulus triggered a significant iLTD of similar
magnitude to what had been reported (Figure 1A; 70.9% ±
1.5% of baseline, n = 8). In contrast, the same HFS did not
trigger iLTD in slices prepared from animals between P17 and
P21 (Figure 1A; 97.4% ± 1.1%, n = 5). Furthermore, we found
that iLTD could not be induced at P22–P26 or at P27–P32
(Figure 1B; Table S1; P22–P26: n = 7, p = 0.35; P27–P32: n =
6, p = 0.056), then sharply increased in its magnitude between
P33 and P45 and remained stable into adulthood (over P70:
n = 8, p = 4 106). Consistent with the presynaptic location
of the iLTD, we found that the HFS resulted in a significant in-
crease in the paired-pulse ratio (PPR) of two consecutive IPSCs
at P33–P45 and over P70 (Figure 1C; P33–P45: p = 0.011; >P70:
p = 0.0058) but not at earlier time points (P17–P21: p = 0.58; P22–
P26: p = 0.23; P27–P32: p = 0.47).
In adult mice, iLTD in area CA2 requires the activation of
DORs (Piskorowski and Chevaleyre, 2013). Following a transient
application of the selective DOR agonist [D-Pen2,D-Pen5]enkeph-
alin (DPDPE; 5 mM), there was a lasting depression of IPSCs
after P35 (Figure 1D; 73.5% ± 4.2% of baseline, n = 8). At
P26–P30, application of DPDPE induced a depression during
the application, but the amplitude of the IPSCs recovered to a
level similar to the initial baseline upon washout of DPDPE (Fig-
ure 1D; 98.8% ± 2.5%, n = 6, p = 0.31). Consistent with the pre-
synaptic action of DOR activation, the DPDPE application
induced a lasting increase in the PPR after P35 (114.1% ±
4.1%, n = 8) but not at P26–P30 (Figure 1D; 100.6% ± 3.2%;
n = 6). This result indicates that DORs are expressed at inhibitory
synaptic terminals in young mice, but the activation of these re-
ceptors does not trigger a lasting depression of gamma-amino-
butyric acid (GABA) release. Together, these data show that the
iLTD in area CA2 has a late developmental maturation, with a
sharp onset during the end of adolescence.
Postnatal Maturation of the PNN and Role in iLTD
Induction
The DOR-mediated iLTD in area CA2 occurs at pre-synaptic
terminals of PV+ INs (Piskorowski and Chevaleyre, 2013). We
used immunohistochemical techniques to determine if there
are any corresponding changes associated with PV+ IN density
in this region during this developmental time period. Using
RGS14 staining to label CA2 pyramidal cells, we examined the
density of PV+ INs in areas CA1, CA2, and CA3 at four age
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Figure 2. The Density of the PNN Associated with PV+ Synapses in Area CA2 Increases at the End of Adolescence, and Its Integrity Is
Required for the iLTD
(A) Area CA2 of a P50 mouse hippocampus stained for CA2 PN marker RGS14, PNN marker Wisteria floribunda agglutinin (WFA), and parvalbumin (PV). Arrows
mark the boundaries of area CA2. Far right: overlay of staining for PNN (magenta) and PV (green)
(B) Summary graph of the quantification of PV+ cells and PNN+ INs at different ages, showing that these two populations of cells are highly enriched in area CA2 at
all ages studied. The percentage of co-expression between PV and the PNN show that most PNN+ cells also express PV.
(C) Top: high-magnification images of staining for PNN, PV, and VGAT. Bottom: the expression intensity profiles corresponding to the labeled region of interest in
the stratum pyramidale (SP) of area CA2, showing that the PNN is in close proximity to inhibitory synapses from PV+ INs.
(D) Staining for the PNN and RGS14 in area CA2 at P17, P29, P35, and P50. Bottom graph: the quantification of the ratio of the mean PNN intensity (excluding
PNN+ INs) over RGS14 intensity in area CA2 shows that a large fraction of the PNN surrounding PNs matures after P30.
(legend continued on next page)
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ranges. We found that the density of PV+ cells in mice was
higher in area CA2, compared to the other hippocampal areas,
at all ages (Figures 2A and 2B). The PNN in area CA2 is
extremely dense (Celio, 1993). We labeled the PNN with
biotin-linked Wisteria floribunda agglutinin (WFA). All hippo-
campal CA regions contained cells that had soma and dendritic
regions that were intensely labeled by WFA. The density of
these cells was highest in area CA2, and the majority of the
intensely labeled cells were PV+ at all ages (Figure 2B; at P50,
CA2: 76.8% ± 2.4%, CA1: 84.1% ± 2.1%, CA3: 86.7% ±
2.3%). These data indicate that the number of PV+ INs sur-
rounded by the PNN does not change during the maturation
of the iLTD.
Numerous studies have shown a dense PNN staining around
PV+ IN soma and dendrites but also a diffuse labeling around
the soma and proximal dendrites of CA2 PNs (Figures 2A and
S1A; Carstens et al., 2016; Celio, 1993). The soma of PNs is
mostly devoid of excitatory synapses (Megı´as et al., 2001), and
we postulate that in area CA2, the PNN surrounding the PN
soma is associated with the basket cell terminals of PV+ INs.
Indeed, WFA staining was present surrounding the PV+ basket
terminals encircling the soma of CA2 PNs (Figure 2C). To ensure
that the PV staining around the soma of CA2 PNs corresponded
to synaptic terminals and not to dendritic processes, we also co-
stained for the vesicular GABA transporter (VGAT), a marker
localized at inhibitory axonal terminals. We found that both
PNN and PV staining profiles were very similar to the VGAT
expression profile (Figure 2C). These data are consistent with
the premise that the diffuse PNN staining surrounding CA2
PNs is associated with basket cell terminals from PV+ INs.
We then examined this diffuse PNN staining surrounding
PN soma at different ages. We measured the mean fluores-
cence intensity in the different hippocampal layers of area
CA2, as delimited by RGS14 staining (Figures 2D and S1),
and excluded regions immediately surrounding the intensely
labeled PNN+ PV+ IN soma. We found that the intensity of
this diffuse WFA staining did not change between P17 and
P22–P29 (Figures S1A and S1B) but significantly increased
at P35 and P50. To ensure that the different PNN intensities
did not result from a difference in fixation or antibody penetra-
tion at different ages, we performed two additional controls.
First, we measured the intensity of the PNN staining in the
same slices in area CA1. We found no change in the PNN in-
tensity in this area (Figure S1B). Second, as the expression
level of RGS14 is stable in the hippocampus during this devel-
opmental period (Evans et al., 2014), we measured the inten-
sity of RGS14 staining at different ages and used these inten-
sity values as an internal control. We found that the PNN
density normalized to RGS14 was stable between P17 and
P22–P29 but displayed a significant increase at P35 and at
P50 (Figure 2D). Therefore, because the emergence of this(E) Incubation of acute brain slices (>P35) in chondroitinase ABC (ChABC) results
slices stained with WFA following a 2-h incubation in ACSF with vehicle (top) or
(F) Slices previously incubated in ChABC showed a much smaller iLTD following
circles, n = 7). Averaged sample traces at the time points indicated by numbers are
change in PPR following HFS (bottom) as compared to controls (top).
Error bars show SEM.
1102 Cell Reports 29, 1099–1112, October 29, 2019diffuse staining in area CA2 coincides with the emergence of
the iLTD, we postulated that the PNN might play a role in
iLTD induction.
We incubated hippocampal slices in Chondroitinase ABC
(ChABC), thereby degrading the PNN in the entire slice, as
shown by the loss of WFA staining in slices incubated with
ChABC for 2 h (Figure 2E). After the ChABC incubation, the
HFS induced a small iLTD (Figure 2F; 89.6% ± 4.8%, n = 5)
that was significantly smaller than the iLTD obtained in the
control slices (64.2% ± 2.6%, n = 7). After the ChABC incuba-
tion, the HFS did not trigger any significant change in the PPR,
in contrast to the effect of the HFS on the PPR in the control
slices (Figure 2F; in control: 119.8% ± 5.9%; in ChABC:
106.3% ± 3.2%). Altogether, these results indicate that the
integrity of the PNN surrounding PN soma is likely associated
with PV+ IN synapses and is required for iLTD induction in
adult mice.
ErbB4 Is Expressed in DOR+ INs and Controls GABA
Release in Area CA2
Within the PNN, there are many extracellular or transmembrane
signaling molecules that can modulate neurotransmitter release.
We postulate that neuregulin 1 (NRG1) and its receptor ErbB4
may play roles in regulating inhibitory transmission and plasticity
in area CA2. The activation of ErbB4 by NRG1 has been reported
to affect GABA release in several structures (Chen et al., 2010;
Woo et al., 2007). ErbB4 is expressed by PV+ INs in the hippo-
campus, but it is not detected in PNs (Vullhorst et al., 2009). If
ErbB4 signaling underlies the dependence on PNN integrity of
the iLTD induction, it must be co-expressed by the cells that
also express DORs. In the hippocampus, DORs are nearly exclu-
sively detected in PV+ INs; however, only a fraction of PV+ INs
(40%) express DORs (Erbs et al., 2012). Similarly, ErbB4 is de-
tected in only a fraction of PV+ INs (Bean et al., 2014). The PNN is
also associated with a fraction of PV+ INs. It is unknown whether
the INs that express the DOR also express ErbB4 or the PNN. To
detect DORs, we used a transgenic line of knock-in mice with
GFP-tagged DORs (Scherrer et al., 2006). As previously reported
(Erbs et al., 2012), the vast majority of DOR-expressing neurons
were located in the stratum pyramidale (SP) and stratum oriens
(SO), and only a small fraction of DOR+ cells were detected
in the SR. In these layers, ErbB4+ cells had a very similar local-
ization with DOR+ cells (Figure 3; n = 5 mice). We found that
the vast majority of DOR+ cells in the SO and SR co-expressed
PNN and ErbB4 (Figures 3A and 3B). Similarly, a very high frac-
tion of ErbB4+ cells in these two layers were co-labeled for the
PNN and DOR (Figures 3A and 3B). Together, these data show
that the majority of cells that co-express the DOR and ErbB4
are surrounded by the PNN. This finding is consistent with an
implication of the PNN in iLTD induction, and it raises the ques-
tion as to whether signaling through ErbB4 could be involvedin a nearly complete digestion of the PNN. Example images of two acute brain
2 U/mL ChABC (bottom).
the HFS (filled circles, n = 5) compared to slices incubated with vehicle (open
in the center panel. Slices pre-treatedwith ChABCdo not undergo a significant
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calized in the Same Cells
(A) Triple staining against DOR-GFP (green), ErbB4
(red), and PNN (cyan) demonstrating the cellular
co-localization of these markers.
(B) Left panel: summary graph of the distribution of
cells that express the DOR and ErbB4 in the stra-
tum oriens (SO), stratum pyramidale (SP), and
stratum radiatum (SR). Middle: graph summarizing
the percentage of DOR+ cells that were co-stained
for the PNN, ErbB4, or both. Right: graph sum-
marizing the percentage of ErbB4+ cells that were
co-stained for the DOR, PNN, or both. Error bars
show SEM.in the control of GABA transmission and plasticity from INs that
also express the DOR.
In the cortex and area CA1, activation of ErbB4 by exogenous
application of NRG1was shown to increase GABA release (Chen
et al., 2010; Woo et al., 2007). Application of the soluble active
form of NRG1 (1 nM) in area CA2 did not alter evoked IPSC
amplitudes or the PPR (Figure 4A; IPSC: p = 0.7, n = 5; PPR:
p = 0.66). Further, exogenous NRG1 application also had no ef-
fect on spontaneous IPSC (sIPSC) amplitude and frequency
(Figure 4B; amplitude: n = 5, p = 0.14; frequency: p = 0.59).
This result suggests that either ErbB4 does not control GABA
release in area CA2, or ErbB4 is already activated by endoge-
nous NRG1. To explore further, we applied the ErbB4 inhibitor
AG1478 to determine if basal GABA release in area CA2 is
under the control of the endogenous NRG1. Following applica-
tion of AG1478 (5 mM), we observed a large decrease in evoked
IPSCs onto CA2 PNs (67.7% ± 4.6%, n = 6), accompanied by a
significant increase in the PPR (Figure 4C; p = 0.036), indicating
that ErbB4 activation directly affects GABA release. To confirm
that ErbB4 acts presynaptically on GABA release, we also
looked at the effect of the ErbB4 blocker on spontaneous
IPSCs. AG1478 application induced a significant decrease in
the frequency of spontaneous IPSCs (Figure 4D; n = 6, p =Cell Repo0.012). However, in agreement with a
lack of postsynaptic effect, the amplitude
of spontaneous IPSCs was not altered
(Figure 4D; p = 0.08). This result indicates
that in area CA2 of adult mice, the release
of GABA is under the control of ErbB4
and is tonically activated by endogenous
NRG1. To ensure that the decrease in
IPSC amplitude mediated by the ErbB4
blockade did not result from a decrease
in PV+ cell excitability, and to address
whether ErbB4 could affect GABA
release by directly acting at the synaptic
terminals, we examined how inhibiting
ErbB4 altered action potential (AP)-inde-
pendent miniature IPSCs (mIPSCs).
Application of AG1478 induced a signifi-
cant decrease in mIPSC frequency (Fig-
ures 4E and 4F; 85.1% ± 3.0%, n = 5;
p = 0.023) without altering the amplitude(96.9% ± 3.8%, p = 0.47). With the change in the PPR of
evoked IPSCs, these data strongly indicate that ErbB4 is
located at PV+ INs’ axon terminals and controls GABA release.
Altogether, our data show that in contrast to the increase in
inhibitory transmission mediated by the application of exoge-
nous NRG1 in area CA1, the positive modulation of GABA
release by ErbB4 in area CA2 is already maximal with endoge-
nous NRG1.
We have previously shown that decreasing PV+ IN transmis-
sion via DOR activation strongly increases the excitatory drive
between CA3 and CA2 via an increase in excitation/inhibition
balance, and it results in CA2 PN AP firing (Nasrallah et al.,
2015). If ErbB4 controls GABA release from the same popula-
tion of INs expressing DORs, then blocking ErbB4 should in-
crease the excitatory drive and AP firing in CA2 PNs. Applica-
tion of the ErbB4 blocker AG1478 induced a large increase in
field potential (fPSP) in response to the CA3 input stimulation
(Figure S2A; 154.6% ± 11.8%, n = 5, p = 0.009). This increase
in fPSP was abolished in the presence of GABAR blockers, con-
firming that it resulted from a dis-inhibitory mechanism.
Following application of AG1478, a population spike emerged
in area CA2 at both 20- and 30-V stimulation intensities (Fig-
ure S2B: p = 0.024, n = 4). Thus, blocking ErbB4 led to therts 29, 1099–1112, October 29, 2019 1103
A B
C D
E F
Figure 4. Signaling through ErbB4 Controls
GABA Release in Area CA2 of Adult Mice
(A) Summary graph showing the lack of effect of
application of the exogenous soluble form of
NRG1 (1 nM) on the IPSC amplitude. Inset: aver-
aged sample traces at the indicated time points.
Right: the PPR was unchanged by application of
exogenous NRG1 (n = 5).
(B) NRG1 application had no effect on the fre-
quency (left) or amplitude (right) of sIPSCs re-
corded in CA2 PNs (n = 5).
(C) Summary graph of the effect of the ErbB4 in-
hibitor AG1478 on the amplitude of IPSCs re-
corded in CA2 PNs (n = 6). Inset: averaged sample
traces at the time points indicated. In addition to
decreasing IPSC amplitude, AG1478 (5 mM) also
triggered a significant increase in the paired pulse
ratio (right panel).
(D) The ErbB4 inhibitor AG1478 induced a signifi-
cant decrease in the frequency (left) but not in the
amplitude (right) of spontaneous IPSCs (n = 6).
(E) Left: example traces of miniature IPSCs
(mIPSCs) recorded in a CA2 PN in control condi-
tions and after the application of AG1478. Right:
summary graph of mIPSC frequency during
application of AG1478 (n = 5).
(F) AG1478 induced a significant decrease in
mIPSC frequency (left) but did not affect mIPSC
amplitude (right) (n = 5). Error bars show SEM.same change in the excitatory drive and AP firing in CA2 PNs as
did activation of the DORs, supporting the idea that these two re-
ceptors act on the same inhibitory terminals.
Signaling through NRG1/ErbB4 Is Required for iLTD
Induction
Because GABA release in area CA2 is under the control of
ErbB4 activation, we tested if signaling through NRG1/ErbB4
might also be involved in the iLTD. We applied the ErbB4
inhibitor AG1478 to slices for 30 min and then applied the
HFS. We found that the HFS did not evoke any iLTD in the
presence of AG1478 (Figure 5A; n = 7, p = 0.637), whereas
the HFS could evoke normal iLTD in interleaved control slices
(n = 8, p = 0.00002). Furthermore, the PPR was not changed
by the HFS in the presence of AG1478 (Figure 5A; n = 7, p =
0.4) but significantly increased in the control slices (Figure 5A;
n = 8; p = 0.0087).
To ensure that the impaired iLTD induction following the
blockade of ErbB4 is not due to reduced enkephalin release,
we directly activated DORs by DPDPE application. In the pres-
ence of AG1478, DPDPE did not trigger iLTD or any lasting
change in the PPR (Figure 5B; IPSC: 97.9% ± 1.7%, n = 6,
p = 0.11; PPR: 98.1% ± 5.2%, n = 6, p = 0.78). These data
are consistent with the fact that inhibition of ErbB4 decreases1104 Cell Reports 29, 1099–1112, October 29, 2019GABA release from the same neurons
that express the DOR; therefore, block-
ing ErbB4 occluded a further depression
by DOR activation.
We also tested whether NRG1 could
affect the iLTD. In the presence ofthe soluble form of NRG1, the HFS was ineffective at inducing
the iLTD (Figure 5A; 96.6% ± 1.5% of baseline, n = 5, p =
0.087) and produced no significant change in the PPR (Fig-
ure 5A; n = 5, p = 0.091). Therefore, even though exogenous
NRG1 application had no effect on the basal transmission
because of the endogenous activation of ErbB4 (see Figure 4),
the presence of exogenous NRG1 prevented iLTD induction.
One possible explanation is that the endogenous activation
of ErbB4 is decreased following iLTD induction. Indeed,
neuronal activity regulates numerous enzymes in the extracel-
lular matrix (Dzwonek et al., 2004). Therefore, it is possible
that a decrease in NRG1 availability or in ErbB4 signaling oc-
curs following the tetanus. To test this, we applied NRG1
5 min after the tetanus. We found that following the NRG1
application, the depression in IPSCs was not maintained,
and GABA transmission returned to a value that was signifi-
cantly different from the depression observed in interleaved
control slices (Figure 5C; n = 6 and 6, p = 0.00032). In addition,
the change in the PPR at the end of the experiment was also
significantly smaller after the NRG1 application (Figure 5C; n =
6 and 6, p = 0.026). These data are consistent with the idea
that part of the NRG1-ErbB4 action on GABA release was
downregulated after the HFS, and exogenous activation of
ErbB4 prevented the maintenance of the iLTD.
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Figure 5. NRG1/ErbB4 Signaling Is Required for DOR-Mediated
Plasticity
(A) Incubation of slices in AG1478 (black circles, n = 7) or NRG1 (gray circles,
n = 5), followed by continuous application of these drugs, prevented iLTD in-
duction by the HFS. The iLTD was normal in interleaved control slices (white
circles, n = 8). Top: averaged sample traces at the time point indicated. The
increase in the PPR observed in control slices was also prevented by the
presence of AG1478 or NRG1 (right).
(B) Blockade of ErbB4 by AG1478 also prevented the effect of the DOR agonist
application on the IPCS amplitude and on the PPR (n = 6). Inset: averaged
sample traces at the time point indicated by numbers.The Effect of NRG1/ErbB4 Signaling onGABARelease Is
Age Dependent
Both ErbB4 and NRG1 are expressed early during development
and control several processes such as migration and matura-
tion of PV+ cells (Mei and Xiong, 2008). However, it is unknown
whether ErbB4 can control GABA transmission in young ani-
mals and if this may underlie the lack of iLTD in young mice.
To test this, we examined the effect of AG1478 on inhibitory
transmission in P22–P27 mice. In contrast to what we observed
in the adult mice, application of AG1478 had no effect on the
evoked IPSC amplitude (Figure S3A; n = 6, p = 0.13) or on
the PPR (n = 6, p = 0.71). In addition, the AG1478 application
did not change the frequency or amplitude of sIPSCs (Fig-
ure S3B; frequency: p = 0.66; amplitude: p = 0.84, n = 6). We
then asked if the lack of action of the ErbB4 blocker might
result from a lack of endogenous activation by NRG1 or from
a lack of control of GABA release by ErbB4. We found that
exogenous NRG1 (1 nM) application had no effect on the
evoked IPSC amplitude (Figure S3C; n = 5, p = 0.29) or on
the PPR (p = 0.062) in P22–P27 mice. Furthermore, NRG1
also did not change the frequency or amplitude of sIPSCs at
this age (Figure S3D; frequency: p = 0.61; amplitude: p =
0.34, n = 5). We also tested lower (0.1 nM) and higher
(10 nM) concentrations of NRG1 and still found no effect on
the evoked IPSC amplitude or the PPR (Figures S3E and
S3F). Therefore, these data show that the modulation of
GABA release by ErbB4 is age dependent. In adult mice,
GABA transmission is positively modulated by the endogenous
activation of ErbB4. In young mice, endo- or exogenous NRG1
had no action on GABA transmission, suggesting the ErbB4 is
not expressed at the synapse and/or is not coupled to GABA
release.
DOR and ErbB4 Engage Different Signaling Pathways
Our data indicate that both DORs and ErbB4 are required for
iLTD induction. Therefore, we wondered whether these two
receptors might use the same signaling pathway. DORs are
known to activate G-proteins negatively coupled to adenylyl
cyclase (Quock et al., 1999). Thus, we wondered whether the
cyclic AMP (cAMP)/protein kinase A (PKA) pathway might be
involved in iLTD. We incubated slices for 30 min in the PKA
blocker PKI 14–22 amide (PKI; 1 mM) and continuously applied
it throughout the plasticity measurement. Following the PKA
block, the HFS did not trigger any significant iLTD (Figure 6A;
n = 5, p = 0.052) or changes in the PPR (p = 0.59). In contrast,
we observed in interleaved control experiments a significant
depression of IPSCs (n = 5, p = 0.0004) and a change in PPR
(p = 0.028) after the HFS. To ensure that the lack of iLTD did
not result from a lack of enkephalin release, we also tested
the effect of the DOR agonist DPDPE in the presence of PKI.
DPDPE did not induce any depression of the IPSC amplitudes
with the PKA blocked (Figure 6B; p = 0.79, n = 5) and also did
not affect the PPR (p = 0.18). These data confirm that the PKA
is required for the depression of GABA release mediated by(C) Application of NRG1 5 min after tetanus (black circles, n = 7) reverses the
IPSC depression, and an increase in the PPR is observed in control slices
(white circles, n = 6). Error bars show SEM.
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Figure 6. DOR and ErbB4 Engage Different
Signaling Pathways, but Their Action on
GABA Release Is Dependent on the PNN
Integrity
(A) Blockade of PKA with PKI 14–22 amide
completely abolished the iLTD induction and
change in the PPR induced by a tetanus (black
circles, n = 5). Slices were incubated 30 min in
PKI and recorded in the continuous presence of
PKI.
(B) In the presence of PKI, DOR activation by
DPDPE had no effect on GABA transmission
(black circles, n = 5). In contrast, the PKA
blockade did not affect the depression of IPSCs
induced by the ErbB4 blocker AG1478 (white
circles, n = 5).
(C) Application of DPDPE resulted in a signifi-
cantly smaller depression of IPSCs in slices
previously incubated in ChABC (filled circles,
n = 5) as compared to control slices (open
circles, n = 6). Top: averaged sample traces
at the time points indicated by numbers.
Right: prior treatment by ChABC prevents a
significant change in the PPR following DPDPE
application.
(D) In slices previously incubated in ChABC (black
circles, n = 5), blockade of ErbB4 by AG1478 re-
sulted in a significantly smaller depression of
IPSCs compared to control slices (white circles, n = 5). The change in the PPR was also prevented by previous incubation in ChABC. Top: averaged sample
traces at the time points indicated. Error bars show SEM.the DOR. Next, we tested whether ErbB4 action on GABA
release also involves the PKA. We found that in presence
of PKI, AG1478 induced a large depression of the IPSC ampli-
tudes (Figure 6B; p = 0.0012, n = 5) and an increase in the PPR
(p = 0.005). Therefore, these data show that the DOR and
ErbB4 use different signaling pathways to control GABA release
in area CA2.
Next, we asked whether the PNN plays a role in the DOR-
and ErbB4-mediated control of GABA release. First, we tested
the consequence of PNN degradation on the decrease in GABA
release mediated by the DOR activation. In slices incubated
with ChABC, DPDPE application had a smaller effect on synap-
tic transmission (Figure 6C; n = 5) and the PPR, compared to
slices incubated in vehicle (n = 6, IPSC: p = 0.003; PPR: p =
0.00011). These data suggest that the PNN is required for the
modulation of GABA release by the DOR activation. We also
tested the effect of the PNN degradation in area CA1 on the
DOR action. In area CA1, the PNN is not detected at basket
cell terminals, and activation of the DOR resulted in a transient
decrease in inhibitory transmission from PV+ INs (Piskorowski
and Chevaleyre, 2013). Application of DPDPE resulted in a
transient depression of IPSCs that returned to baseline for
both control and ChABC-treated slices (Figure S4; p = 0.92).
Furthermore, no lasting change was detected in the PPR for
both conditions (control: n = 5, p = 0.59; ChABC: n = 5, p =
0.20). The transient depression of the IPSC amplitude at the
end of DPDPE application was identical in both conditions
(p = 0.95). Therefore, these data show that degradation of
the PNN in area CA1, which primarily surrounds soma and den-
drites of INs, did not affect the action of the DOR activation on
GABA transmission. We then tested the effect of PNN degrada-1106 Cell Reports 29, 1099–1112, October 29, 2019tion on the control of GABA release by ErbB4. We found that
AG1478 induced a very small depression of IPSCs in ChABC-
treated slices (Figure 6D; n = 5), compared to controls (n =
5). AG1478 also had very little effect on the PPR in ChABC-
treated slices (Figure 6D; n = 5), compared to controls
(n = 5). Therefore, these data indicate that when the PNN is
degraded, the positive action of ErbB4 on GABA release is
lost, suggesting that PNN integrity is required for the basal
activation of ErbB4 by endogenous NRG1.
DOR-Mediated iLTD in CA2 Is Involved in Social Memory
Formation
The late emergence of the iLTD suggests that this plasticity may
be involved in higher cognitive processes rather than synapse
and network establishment. If DOR-mediated iLTD in area CA2
plays a role in social memory formation, one could make the
following two predictions. First, the ability of a mouse to form
social memories should emerge during development at the
same time as the iLTD. Second, disruption of the iLTD in adult
mice should also disrupt performance in a social memory task.
To test these predictions, we first examined the ability of a
mouse to form social memories before and after the onset of
iLTD with the five-trial social memory test (Kogan et al., 2000;
Figure 7A). In adult control mice, the interaction time was
significantly reduced in trials 3 and 4 with the same familiar
mouse (Figure 7B; n = 8). When a novel mouse was introduced
in trial 5, the subject mouse displayed an expected rebound of
interaction time. In 28-day-old mice, there was no significant
decrease in the interaction time in trials 2–4, compared to
trial 1 (Figure 7B; n = 10). These data indicate that before the
emergence of the DOR-mediated iLTD in area CA2, juvenile
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mice show a performance in this task that is consistent with
reduced social memory.
Next, we tested whether disrupting the iLTD specifically in
area CA2 would also affect social memory in adult mice. We
used two different strategies to test this hypothesis. First,
because iLTD is dependent on the PNN integrity, we performed
targeted bilateral stereotaxic injections into area CA2 to deliver
either a control saline solution or a ChABC solution. Then,
7 days following the injection, we performed the same social
memory test on the two groups of animals. Behavioral data
were only used from animals that had injection sites properly
targeted to area CA2. After the targeted injection of 0.1 ml of
ChABC in area CA2, the intensity of the PNN staining was
slightly reduced in areas CA1 and CA3 but displayed a much
larger decrease in area CA2 (Figure 7C). We found that the
initial interaction time between the subject mouse and a novel
mouse did not differ between ChABC- and vehicle-injected-
mice, suggesting that sociability is not affected by reducing the
PNN in area CA2. In mice injected with saline, a significant
decrease in the interaction time was observed during trial 2
(Figure 7D; n = 10), and a further decrease was observed in trials
3 and 4. For mice injected with ChABC, no significant decrease
in interaction time between the subject mouse and the familiar
mouse was observed, even during trial 4 (Figure 7D; n = 12).
Therefore, these results indicate that digestion of the PNN in
area CA2 is sufficient to prevent social memory formation.
Because we cannot exclude that a small-level PNN degrada-
tion in areas CA1 or CA3 could also contribute to the behavior,
we performed two hippocampal-dependent but CA2-indepen-
dent tasks after ChABC injection in area CA2. First, we moni-
tored the distance traveled in an open field and the time spent
in the center of the arena. We found that the total distance was
not different between saline- and ChABC-injected mice (PBS:
n = 6; ChABC: n = 8, p = 0.62). Similarly, the time spent in the
center was not different between saline- and ChABC-injected
mice (PBS: n = 6; ChABC: n = 8, p = 0.081). These data suggest
that both general locomotor activity and anxiety are not altered
following PNN degradation in area CA2. Next, we performed a
novel object location task. During acquisition of the task, both
saline- and ChABC-injected mice spent the same amount of
time exploring the two different objects (PBS: n = 6, p = 0.26;Figure 7. Social Memory Matures in Parallel to the iLTD and Requires
(A) Left: illustration of the experimental protocol used to test social memory format
location task (NOL).
(B) In P60mice, investigation time decreased during successive exposures and w
significant decrease in interaction time was observed in trials 2–4 (n = 10). Right
(C) Staining for the PNN (green) and for the CA2 marker PCP4 (red) in mice injec
staining in area CA2 is observed in mice injected with ChABC. Scale bar: 100 mm
(D) Mice injected with PBS show a normal decrease in interaction time in trials 2–4
for mice injected with ChABC (n = 12). The normalized values for the interaction tim
mice on trials 2–4, whereas no significant change was observed in mice injected
(E) Both PBS- and ChABC-injected mice display a preference for the displaced o
(F) Staining for GFP (green), PCP4 (red), and Cre (white) in DOR-floxmice injected w
the right. Arrows show GFP-positive, PCP4-negative neurons (putative INs). Note
Scale bar: 50 mm.
(G) Mice injected with AAV GFP show a large decrease in interaction time in trial 2
AAV cre-GFP (n = 8) only show a significant decrease in interaction time in trial 4
(H) Both AAV GFP- and AAV cre-GFP-injected mice display a preference for the
1108 Cell Reports 29, 1099–1112, October 29, 2019ChABC: n = 8, p = 0.28). During the test, both PBS- and
ChABC-injected mice spent significantly more time exploring
the displaced object compared to the fixed object (Figure 7E;
PBS: p = 0.03; ChABC: p = 0.00079). Therefore, this result sug-
gests that the impairment in social memory formation after
ChABC injection was the result of the PNN digestion in area
CA2 and not in areas CA1 or CA3.
We have shown that PNN integrity in area CA2 is required for
iLTD induction. However, we employed a second strategy to
target area CA2 in order to rule out alterations of DOR-meditated
plasticity in area CA3, as there is a high expression of DORs in
inhibitory neurons in area CA3 (Erbs et al., 2012), and CA3 has
recently been implicated in the encoding phase of social memory
(Chiang et al., 2018). In contrast to a previous study (Leroy et al.,
2017), we found that DPDPE application induced a large and
significant decrease in inhibitory transmission in CA3 PNs (Fig-
ure S5; n = 5, p = 0.005), along with an increase in the PPR
(n = 5, p = 0.02), consistent with a presynaptic action of the
DOR on GABA release. Our second strategy took advantage of
the binding of adeno-associated viruses (AAVs) to glycan re-
gions of host cell receptors (Mietzsch et al., 2014). The PNN pre-
sent in area CA2 is particularly rich in proteoglycans and sialic
acids (Br€uckner et al., 2003), and we harnessed this aspect of
the extracellular matrix to knockout DOR receptors selectively
in area CA2. We used a DOR-floxmouse line (Orpd1 fl/fl) and per-
formed a very small volume targeted injection to area CA2 of an
AAV serotype 5 virus expressing GFP-tagged Cre recombinase
(AAV5-cre-GFP) or control virus expressing GFP (AAV5-GFP).
Then, 6 weeks after viral injection, we tested the performances
of the social memory and novel object location tasks. Following
the behavioral testing, the specificity of the viral infection was
confirmed post hoc (Figure 7F). Behavioral data were only
used from animals that had injections properly targeted to area
CA2. The viruses led to GFP expression in PCP4-expressing
PNs as well as putative INs in area CA2, as these cells were
smaller in size and PCP4 negative, yet located within the
PCP4+ region (Figure 7F).
Mice injected with the control virus displayed a learning curve
similar to that of the control mice, with a large decrease in
interaction time observed during trials 2–4 and a rebound of
interaction during trial 5 (Figure 7G; n = 7). In mice injectedthe PNN Integrity in CA2
ion. Right: illustration of the experimental protocol used to perform novel object
as significantly lower in trials 3 and 4 (n = 8) compared to trial 1. In P28mice, no
panel shows the normalized investigation time at P60 and P28.
ted with ChABC or saline solution (PBS). Right: a large decrease in the PNN
.
(n = 10). The interaction time did not decrease on trial 2–5 as compared to trial 1
e show that a significant decrease in interaction was observed in PBS-injected
with ChABC.
bject in the NOL task.
ith AAVGFP or AAV cre-GFP in area CA2. Higher magnifications are shown on
the nuclear localization of the cre-GFP signals in AAV cre-GFP-injected mice.
and a significant decrease in trials 3 and 4 (n = 7). In contrast, mice injected with
, indicating that acquisition of social memory is delayed.
displaced object in the NOL task. Error bars show SEM.
with AAV-cre-GFP, a significant decrease in interaction time
between the subject and the familiar mouse was observed
only during trial 4 (Figure 7G; n = 9). To ensure that CA2-indepen-
dent but hippocampal-dependent tasks were not affected by
the viral injection, we also looked at the open field and the novel
object location tasks. In the open field task, both AAV-cre-GFP
and AAV-GFP mice traveled the same distance in the arena
(AAV-GFP: n = 7; AAV-cre-GFP: n = 9, p = 0.221) and
spent the same amount of time in the center (AAV-GFP: n = 7;
AAV-cre-GFP: n = 9, p = 0.397). In the novel object location
task, both AAV-cre-GFP and AAV-GFP mice spent similar
amounts of time exploring the two novel objects (AAV-GFP:
n = 7, p = 0.20; AAV-cre-GFP: n = 9, p = 0.82). Both mice also
spent more time exploring the displaced object (Figure 7H;
AAV-GFP: p = 0.026; AAV-cre-GFP: p = 0.006). Altogether, these
data show that preventing DOR-mediated plasticity in area CA2
did not alter general locomotor activity and anxiety. However, the
lack of the DOR in area CA2 delays the acquisition of social
recognition memory.
DISCUSSION
In this study, we show that the DOR-mediated plasticity of GABA
release from PV+ INs in area CA2 has a reversed developmental
profile compared to many forms of plasticity. Its emergence at
the end of adolescence coincides with the maturation of the
PNN and ErbB4 signaling at PV+ IN synapses, and both the
PNN and ErbB4 are required for the induction of the plasticity.
Furthermore, we provide evidence that DOR-mediated plasticity
plays a facilitatory role in social memory formation and emer-
gence of this memory at the end of adolescence.
Model for DOR-Mediated iLTD at PV+ IN to PN Synapses
Wepropose the followingmodel for iLTD induction (Figure S6). In
juvenile mice, the action of DOR activation is transient, and
transmission recovers to basal levels upon washout of the
agonist or 10–15min after tetanus; ErbB4 is either not expressed
at the synapse, or it is expressed but its activation is not linked
to GABA release. In adult mice, PV+ INs that express DORs
also express ErbB4; ErbB4 activation controls GABA release
and in basal conditions is activated by endogenous NRG1. After
the HFS, GABA release is reduced through the DOR activation.
The tetanus also leads to a loss of ErbB4 activation, either
through a direct link between the DOR and ErbB4 or through a
change in the availability of soluble NRG1. The loss of positive
action of ErbB4 can then maintain the depression of GABA
release, thus leading to iLTD. Reactivation of ErbB4 with exoge-
nous NRG1 just after the tetanus restores GABA transmission
and prevents iLTD. The PNN appears to play a critical role in
iLTD induction by allowing ErbB4 to be activated by NRG1. After
PNN degradation, blockade of ErbB4 has no effect on GABA
transmission, and the iLTD cannot be induced and is likely
occluded. Other manipulations that decrease GABA release
from PV+ INs, such as the DOR agonist application or direct
ErbB4 blockade, also occlude the iLTD. Therefore, these data
highlight a critical role of PNN maturation around PV+ IN synap-
ses in the emergence of the iLTD, likely by allowing ErbB4 action
on GABA release.PNN Maturation during Late Adolescence Controls the
Emergence of Plasticity at PV+ Synapses in Area CA2
Several studies have reported an increase in the PNN staining
during postnatal hippocampal development (Carstens et al.,
2016; Horii-Hayashi et al., 2015; Yamada and Jinno, 2013).
Here, we report an increase in the PNN likely associated with
inhibitory terminals on CA2 PNs during late adolescence. It
was initially proposed that the PNN around CA2 PN soma could
be associated with inhibitory synapses from basket cells (Celio,
1993). More recently, it was proposed that the PNN around
CA2 PNs serves to regulate excitatory transmission and plas-
ticity during early postnatal development (Carstens et al.,
2016). The soma of hippocampal PNs is virtually devoid of
excitatory synapses and is instead surrounded by inhibitory ter-
minals from basket cells (Megı´as et al., 2001). In area CA2, the
fraction of basket cell terminals from PV+ INs around the soma
of PNs is much higher than in areas CA1 or CA3 (Ribak et al.,
1993). Therefore, we postulate that the PNN around the soma
of CA2 PNs is associated with inhibitory synapses fromPV+ cells
and, thus, would be able to influence GABA release. In agree-
ment with this idea, we found that degradation of the PNN pre-
vents DOR-mediated iLTD induction, a plasticity known to occur
at pre-synaptic terminals of PV+ INs (Piskorowski and Cheva-
leyre, 2013). DOR receptors are expressed at synaptic terminals
of PV+ INs (Rezaı¨ et al., 2012), and we show that PNN degrada-
tion strongly reduces the effect of their activation on GABA
release. Finally, we found that endogenous activation of ErbB4
is required for iLTD induction and controls both the amplitude
of evoked IPSCs and the frequency of mIPSCs. Therefore, these
data demonstrate that the PNN-associated signaling through
ErbB4 is involved in controlling the release of GABA from PV+
IN terminals.
Inhibitory transmission from PV+ INs onto CA2 PNs displays
a long-term depression mediated by DOR activation (Piskorow-
ski and Chevaleyre, 2013). We show that this plasticity is not
expressed in juvenile mice but shows a steep increase after
P30. These data are in sharp contrast to many forms of plasticity
that are prominent during postnatal development but are
considered constrained by maturation of the PNN at the end of
adolescence. For instance, maturation of the PNN has been
shown to be a break for plasticity in the cortex and to control
the end of the critical period (Hensch, 2005). Our data suggest
that components of the PNN can also have a permissive role
for synaptic plasticity by supporting the iLTD induction in area
CA2. Several results strongly suggest that maturation of the
signaling through the PNN is required for the emergence of
iLTD: (1) the intensity of the PNN staining associated with inhib-
itory basket terminals in area CA2 shows a large increase in
intensity after P30; (2) PV+ cells that express the PNN-associ-
ated ErbB4 also express DORs; (3) disrupting PNN integrity in
adults also disrupts iLTD induction; and (4) signaling through
ErbB4/NRG1 controls the probability of GABA release in adults
but not in young mice and is required for iLTD induction.
Together, these data show that in contrast to many forms of
plasticity that are constrained by maturation of the PNN at the
end of adolescence, signaling within the PNN can be permissive
for the emergence of new plasticity and potentially higher cogni-
tive functions.Cell Reports 29, 1099–1112, October 29, 2019 1109
The Role of Plasticity at PV+ Synapses in Area CA2 in
Social Memory Formation
Area CA2 plays a critical role in social memory formation. This
form of memory is impaired when tetanus toxin is expressed in
CA2 PNs (Hitti and Siegelbaum, 2014), indicating that transmis-
sion from CA2 PNs is required. In agreement, social memory is
also impaired in a mouse model of the 22q11.2 deletion syn-
drome, where excitability of CA2 PNs is strongly reduced (Pis-
korowski et al., 2016). Normally, CA3 inputs are unable to drive
AP firing in CA2 PNs because of the large feed-forward inhibition
between areas CA3 and CA2 (Chevaleyre and Siegelbaum,
2010; Kohara et al., 2014; Piskorowski and Chevaleyre, 2013).
However, following iLTD induction in area CA2, CA3 inputs are
able to drive AP firing in CA2 PNs (Nasrallah et al., 2015).
Because excitatory CA3-CA2 inputs do not express activity-
dependent long-term-potentiation (LTP) (Zhao et al., 2007), it
is likely that plasticity at inhibitory synapses represents a
primary means of modulating the excitability of CA2 PNs. Our
data provide evidence that iLTD may play an active role in
social memory formation. (1) Social memory matures at the
same time as the iLTD. The lack of social memory in juvenile
mice is not just a generalized inability to learn because mice at
this age or even younger have been shown to learn diverse
tasks such as spatial memory (Ainge and Langston, 2012) or
contextual fear conditioning (Pattwell et al., 2013). These tasks
are dependent on the hippocampus, but they are independent
of area CA2 (Hitti and Siegelbaum, 2014). (2) We show that
localized degradation of the PNN in CA2, a manipulation that
impairs iLTD induction, also impairs social memory formation.
(3) We provide evidence that selective removal of DORs in area
CA2 also affects social memory formation. In contrast to PNN
degradation, this manipulation did not fully block social memory.
Several explanations can be put forward to explain this differ-
ence. In particular, PNN degradation can alter the excitability
of PV+ INs (Bozzelli et al., 2018; Hayani et al., 2018) in addition
to preventing iLTD induction. Therefore, it is likely that PNN
degradation will result in a stronger impairment of PV+ IN phys-
iology than just selective knockout of DORs. The reduced social
memory that we observed after the DOR removal is consistent
with the decrease observed after the DOR antagonist injection
in CA2/CA3 (Leroy et al., 2017). However, using a five-trial social
memory test instead of two trials only, we were able to show that
the interaction times during the second and third trials were
altered, but the interaction time was normal during the fourth
trial. Therefore, these data indicate that social learning is slower
in mice lacking a DOR in area CA2, but thesemice are still able to
form normal social memory.
The data presented here are not only relevant for under-
standing the mechanisms involved in the emergence of new
cognitive functions at the end of adolescence, but they also
provide valuable insights on potentially relevant alterations
occurring during pathologies. Multiple post-mortem studies
have demonstrated that area CA2 is particularly susceptible
during psychiatric diseases and neurodegenerative disorders
(Chevaleyre and Piskorowski, 2016). Furthermore, several
studies have reported that the PNN and ErbB4 signaling are
altered during schizophrenia and Alzheimer’s disease (Berretta
et al., 2015; Iwakura and Nawa, 2013; Soleman et al., 2013).1110 Cell Reports 29, 1099–1112, October 29, 2019The PNN contains neurotrophic factors and is neuroprotective
for PV+ INs against oxidative stress (Cabungcal et al., 2013).
Therefore, a deficit in signaling through the PNN may underlie
the decrease in PV+ IN density observed during these pathol-
ogies. In area CA2, we show that the PNN is also likely located
between the axon terminal of PV+ INs and the soma of PNs,
where it can control synaptic transmission and the plasticity
of GABA release. A large fraction of this PNN matures at
the end of adolescence in parallel to the control of GABA
release mediated by endogenous ErbB4 activation. Therefore,
it is possible that an impaired signaling within the PNN may
underlie the decrease in inhibitory transmission and plasticity
that we observed in a mouse model of the 22q11.2 deletion
syndrome, the highest genetic risk factor for developing
schizophrenia in humans (Karayiorgou et al., 2010; Piskorow-
ski et al., 2016). In agreement with this, both NRG1 and ErbB4
have been linked to schizophrenia (Buonanno, 2010), and
removing ErbB4 from fast-spiking INs is sufficient to cause a
schizophrenia-like phenotype (Del Pino et al., 2013). Further-
more, it has been proposed that signaling through NRG1
and ErbB3/4 is involved in social memory (Moy et al., 2009).
Our data suggest that this effect could be mediated through
plasticity at inhibitory synapses in area CA2, and this pathway
might be altered during schizophrenia.
Altogether, our data show that the maturation of the PNN
and of ErbB4 signaling is a prerequisite for the emergence
of plasticity at PV+ IN synapses in area CA2. Furthermore,
the data also provide evidence that the late maturation of
inhibitory plasticity in area CA2 might be involved in emer-
gence of higher cognitive processes such as social memory
formation.STAR+METHODS
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Chevaleyre (vivien.chevaleyre@parisdescartes.fr). This study did not generate new unique reagents.
EXPERIMENTAL MODEL AND SUBJECT DETAILS
Electrophysiology experiments
All experiments were performed on C57B6 male mice.
Behavioral experiments
C57B6J male mice (Charles River, France) were used for behavioral experiments. They were housed in groups of five since weaning
at P21 in standard breeding cageswith food andwater ad libitum, andwere placed at a constant temperature (23 ± 1C) under diurnal
conditions (light-dark: 8:00AM–8:00PM). Mice were tested during the first half of the light period.
Immunohistochemistry
Histology experiments were performed on wild-type C57BL/6J or on DOR-EGFP mice.
METHOD DETAILS
Slice preparation
400 mm transverse hippocampal slices were prepared fromC57BL/6Rj male mice. Animals were euthanized in accordance with insti-
tutional regulations under anesthesia with isofluorane. Hippocampi were removed and placed upright into an agar mold and cut with
a vibratome (Leica VT1200S, Germany) in ice-cold solution containing (in mM): 10 NaCl, 195 sucrose, 2.5 KCl, 15 glucose,
26 NaHCO3, 1.25 NaH2PO4, 1 CaCl2 and 2 MgCl2). The slices were then transferred to 30C artificial cerebral spinal fluid
(ACSF), (in mM: 125 NaCl, 2.5 KCl, 10 glucose, 26 NaHCO3, 1.25 NaH2PO4, 2 Na Pyruvate, 2 CaCl2 and 1 MgCl2) for 30 min
and kept at room temperature for at least 1.5 hr before recording. For experiments using digestion of the PNN, slices were further
incubated in a separate chamber with either Chrondroitnase ABC (2 U / mL; Sigma) and 0.1% bovine serum albumin (BSA) in
ACSF, or with 0.1% BSA in ACSF for 2 hours. All experiments were performed at 33C.
Electrophysiological recordings and analysis
Whole-cell recordings were obtained from CA2 PNs in voltage clamp mode with a patch pipette (3–5 MU) containing (in mM): 135
CsMethylSulfate, 5 KCl, 0.1 EGTA-Na, 10 HEPES, 2 NaCl, 5 ATP, 0.4 GTP, 10 phosphocreatine; pH 7.2; 280–290 mOsm). Series
resistance (typically 12–18 MU) was monitored throughout each experiment and cells with more than 15% change were excluded
from analysis. Before beginning whole cell experiments, we identified the CA2 PNs by somatic location and size. Furthermore,
the cell type was confirmed by several electrophysiological properties as previously described (Chevaleyre and Siegelbaum,
2010). Cells were also filled with biocytin and post hoc labeling of filled cells and imaging was performed to confirm CA2 recording
when necessary.
Synaptic currents were evoked bymono-polar stimulation with a patch pipette filled with ACSF and positioned in themiddle of CA1
SR. The amplitudes of the IPSCs were normalized to the baseline amplitude. A HFS (100 pulses at 100Hz repeated twice, 20 s apart)
was applied following stable baseline. The magnitude of plasticity was estimated by comparing averaged responses at 30-40 min
after the induction protocol with baseline-averaged responses from 0 to 10 min before the induction protocol. We used pClamp10
and Axograph X software for data acquisition and Origin Pro for data analysis. Statistical comparisons were performed using
Student’s t test, ANOVA, Wilcoxon, Mann-Witney or Kruskal-Wallis where appropriate. All drugs were bath-applied following dilution
into the external solution from concentrated stock solutions. Results are reported as mean ± SEM.
Immunohistochemistry
For histology experiments, wt C57BL/6J at P17, P22, P29, P35 and P50 were anesthetized according to institutional regulation and
transcardially perfused with ice-cold phosphate-buffered saline (PBS) followed by 4% paraformaldehyde in PBS. DOR-EGFP mice
were anesthetized with pentobarbital and perfused with ice-cold 4% paraformaldehyde at 20 ml/min for 5 min. The brains were
dissected, post-fixed and 30 mm floating coronal sections were prepared with a Leica 1000S vibratome. 8 serial sections were
selected spanning bregma 1.8 to 2.1. Sections were permeabilized in PBS + 0.2% Triton, followed by incubation in blocking
solution (PBS+0.2% Triton + 3% normal goat serum). Primary antibody incubation was carried out in blocking solution overnight
at 4C. A rabbit anti-parvalbumin antibody (Swant) was used at a dilution of 1:2000, the mouse monoclonal anti-RGS14 antibody
(Neuromab) was used at dilution of 1:300. GFP-DOR signal was amplified with a polyclonal chicken anti-GFP (Abcam) at a dilution
of 1:10000, and ErbB4 was stained with the mouse monoclonal HER-4 antibody (Invitrogen) at a dilution of 1:300. The PNN wase2 Cell Reports 29, 1099–1112.e1–e4, October 29, 2019
stained with Wisteria Floribunda Agglutinin (WFA)-biotinylated (Sigma) diluted at 1:1,000 followed by either alexa-555 streptavidin
(Life Technologies) or alexa-647 streptavidin (Life Technologies) diluted at 1:500. Secondary antibodies were carried out in block so-
lution for 4 hours. Secondary antibodies were Cy3 tagged goat anti-rabbit (Jackson ImmunoResearch), alexa-647 tagged goat anti-
mouse (Life Technologies), Alexa 488 rat anti-chicken (Life Technologies) all diluted at 1:800.
Images were collected with a Zeiss 710 laser-scanning confocal microscope. Z series images consisting of three channels were
collected every 0.9 mmover a total distance of 30 mmper slice. RGS14 staining alone was used to define area CA2. All image analysis
and quantification was performed with ImageJ.
Stereotaxic injection
For PNN degradation, male mice (7-8 weeks old, Charles River, France) were anaesthetized with isoflurane (2%–5%) and placed in a
stereotaxic apparatus (Kopf). Each mouse was submitted to two bilateral injections into the area CA2 of dorsal hippocampus
(1.1 mm anteroposterior, ± 0.6 mmmediolateral and 2.00 mm dorsoventral, and 1.98 mm anteroposterior, ± 2.3 mmmediolat-
eral and 2.05 mm dorsoventral, relative to bregma) of 100 nL of a solution with ChABC (50 U/ml, Sigma, n = 12 mice), or a vehicle
solution (phosphate buffer saline 0.1 M, PBS, n = 10 mice). Lidocaine was applied on the flesh before suturing the skin. The animals
were then allowed to recover for a week before behavioral testing. To selectively knockout DOR in area CA2, DOR-flox mice (line
Orpd1 fl/fl, REF) were submitted to two bilateral injections into area CA2 of 100 nL of rAAV5-hSyn-eGFP or rAAV5-hSyn-Cre-eGFP
solution. Lidocaine was applied on the flesh before suturing the skin. The animals were submitter to behavioral testing 6 weeks after
viral injection.
Behavioral experiments
A total of 40 C57BL/6J male mice (Charles River, France) were used for behavioral experiments. They were housed in groups
of five since weaning at P21 in standard breeding cages with food and water ad libitum, and were placed at a constant temperature
(23 ± 1C) under diurnal conditions (light-dark: 8:00AM–8:00PM). Mice were tested during the first half of the light period, and
the experiments were performed in strict accordance with the recommendations of the European Union (86/609/EEC) and the
French National Committee (87/848). For five-trial social memory test (Kogan et al., 2000), each mouse was first placed for
10 min habituation in a large chamber (25x35 cm) with an empty cylindrical small cage placed in the center (8 cm diameter). Then
a stimulus mouse, from same age and sex, but never encountered before, was introduced in the small cage for four successive trials
of 5min (ITI 10min). On the fifth trial, a novel stimulusmousewas introduced. The direct interactions were scored online by the exper-
imenter. All apparatuses and testing chambers were cleaned with 70% ethanol between animals. Mice were sacrificed 3 hours after
the social memory test.
Locomotor activity was analyzed during the habituation session of the novel object location task (see below). Each animal was
allowed to explore a circular open-field (62 cm diameter, 40 cm-high wall) for 10 minutes. The distance moved in the open field
was measured by means of video tracking software (EthoVision XT, Noldus).
The object location test addresses the ability of mice to discriminate between a novel and a familiar spatial location in an open-field
with a visual cue (striped pattern). During acquisition, two identical objects were placed in themiddle of the open-field. Themice were
allowed to explore for 10min during which the time spent exploring the two objects was recorded. In the test phase held 3 hours later,
identical copies of the sample objects were exposed and one of the two objects was moved to a novel location. The position (left or
right) of the displaced object was chosen pseudorandomly to reduce bias toward a particular position. Mice were allowed to explore
the objects during 10 min. All apparatuses and testing chambers were cleaned with 70% ethanol between animals.
Post hoc histological analysis
Mice were administered pentobarbital before being flush-perfused transcardially with normal saline for 45-60 s. The brains were
removed and bisected, then drop-fixed in 4% PFA/PB 0.1M for 48 hours at 4C, and transferred into a 30% sucrose solution with
0.1% sodium azide for at least 2 days. Coronal sections of 30 mmwere prepared with a sliding microtome (Leica SM2010R) equipped
with a freezing stage (Physitemp BFS-3MP). A series of free-floating sections, from bregma 0.6 to 3.0 and of 150 mm apart, was
used for PCP4 and WFA stainings. Sections were rinsed extensively in PBS with 0.25% Triton X-100 (PBST) before being placed for
15min in a PBS solution with 3%H2O2 and 10%methanol. After twowashes in PBST, the sections were transferred in a 10%normal
donkey serum (NDS) in PBST blocking solution for 1 hour. The sections were then incubated overnight at room temperature in a
PBST/10% NDS solution containing the rabbit anti-PCP4 antibody (Santa Cruz; 1:250) and the Wisteria Floribunda Agglutinin
(WFA)-biotinylated (Sigma; 1:1,000). The next day, sections were incubated for 90 min in a PBST/10% NDS solution with secondary
antibody donkey anti-rabbit Alexa 647 (Molecular Probes; 1:250) and streptavidin-TRITC (Molecular Probes; 1:500). For histological
control of injections and measurements of PNN degradation, 4 hemi-sections were analyzed per animal. PCP4 staining was used to
define area CA2. Images were collected with a Leica DM600B fluorescence microscope, and image analysis and quantification were
performed with ImageJ and Fiji plugin.Cell Reports 29, 1099–1112.e1–e4, October 29, 2019 e3
QUANTIFICATION AND STATISTICAL ANALYSIS
We used pClamp10 and Axograph X software for data acquisition and Origin Pro and GraphPad Prism for data analysis. Statistical
comparisons were performed using Student’s t test and ANOVA. When the distribution was not normal, we used non-parametric test
(Wilcoxon and Mann-Whitney test, see Table S1). Statistical significance was set to p < 0.05 (*** indicates p < 0.001, ** indicates p <
0.01, * indicates p < 0.05). Data are reported as mean ± SEM. Error bars shown in figures represent SEM.
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